Showing results (121-130 of 131) with videos related to

Sort By:
Pageof 14
Proceedings of the National Academy of Sciences of the United States of America|November 19, 2017
Cancer cells induce interleukin-22 production from memory CD4+ T cells via interleukin-1 to promote tumor growthCornelia Voigt, Peter May, Adrian Gottschlich, et al.
BMC Geriatrics|February 14, 2023
Local, collaborative, stepped, and personalized care management for older people with chronic diseases - results from the randomized controlled LoChro-trialGloria Metzner, Lukas Maximilian Horstmeier, Jürgen Bengel, et al.
The EMBO Journal|February 10, 2023
Structural mechanism of CRL4-instructed STAT2 degradation via a novel cytomegaloviral DCAF receptorVu Thuy Khanh Le-Trilling, Sofia Banchenko, Darius Paydar, et al.
Pharmaceutics|September 28, 2024
Cyclin-Dependent Kinase 8 Represents a Positive Regulator of Cytomegalovirus Replication and a Novel Host Target for Antiviral StrategiesDebora Obergfäll, Markus Wild, Mona Sommerer, et al.
Annals of Hematology|January 21, 2026
Prevention, diagnosis and management of community acquired respiratory virus infections including COVID-19 in patients with cancer: 2025 updated evidence-based guideline of the infectious diseases working party (AGIHO) of the German society for hematology and medical oncology (DGHO)Nicola Giesen, Sibylle C Mellinghoff, Elham Khatamzas, et al.
The Journal of General Virology|August 29, 2023
Isolation and genome sequencing of cytomegaloviruses from Natal multimammate mice (Mastomys natalensis)Frederick Hansen, Matej Vučak, Jenna Nichols, et al.
European Journal of Pediatrics|January 6, 2026
Individualized online exercise therapy aids recovery in pediatric long-COVID-findings from an exploratory randomized controlled trialSarah Christina Goretzki, Mara Bergelt, Laurent Weis, et al.
The Lancet Regional Health. Europe|February 20, 2025
2024 update of the AGIHO guideline on diagnosis and empirical treatment of fever of unknown origin (FUO) in adult neutropenic patients with solid tumours and hematological malignanciesMichael Sandherr, Jannik Stemler, Enrico Schalk, et al.
Nature|July 30, 2020
SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19Julian Braun, Lucie Loyal, Marco Frentsch, et al.
Science (New York, N.Y.)|September 1, 2021
Cross-reactive CD4+ T cells enhance SARS-CoV-2 immune responses upon infection and vaccinationLucie Loyal, Julian Braun, Larissa Henze, et al.
Pageof 14